|
|
Table 3.
Human-Horse Comparative Gene Map Using Synteny, Linkage and in Situ
Hybridization (127 Genes)
|
|
Hsaa
|
Locus
|
Locus
name
|
ECAb
|
Methodc
|
Btad
|
Mmue
|
Fcaf
|
Sscg
|
| 1p36.2 |
NPPA |
natriuretic
peptide precursor,
A |
2 |
S |
16 |
4 |
 |
 |
| 1p36.2-p36.13 |
PGD |
phosphogluconate
dehydrogenase |
2p12 |
I,L |
16 |
4 |
C1 |
6q2.2 q2.5 |
| 1p31 |
PGM1 |
phosphoglucomutase
1 |
5 |
L |
3 |
5 |
C1 |
6 |
| 1p13.1 |
NGFB |
nerve
growth factor, |
5 |
S |
3 |
3 |
 |
4q1.6-q2.3 |
| 1q21 |
GBA |
glucosidase, ,
acid |
5 |
S |
3 |
3 |
 |
4 |
| 1q23-q25.1 |
AT3 |
antithrombin
III |
5 |
S |
16 |
1 |
 |
 |
1q31
|
LAMC1
|
laminin,
C1
|
5
|
S
|
16
|
1
|

|

|
| 2p25 |
ODC1 |
ornithine
decarboxylase |
15q27 |
I |
 |
12 |
 |
 |
| 2p21 |
CAD |
carbamoylphosphate
synthetase |
15q25 |
I |
 |
1 |
 |
 |
| 2p21 |
SPTBN1 |
spectrin,
, nonerythrocytic
1 |
15 |
S |
 |
11 |
 |
 |
| 2q14 |
IL1B |
interleukin
1,  |
15 |
S |
2 |
2 |
|
3q1.1-q1.4 |
| 2q12-q14 |
PAX8 |
human
paired
domain |
15 |
S |
 |
2 |
 |
 |
| 2q21 |
LCT |
lactase-phlorizin
hydrolase |
15q21 |
I |
 |
1 |
 |
15q1.3 |
| 2q32.1 |
MSTN |
myostatin |
18 |
S |
2 |
1 |
 |
 |
| 2q24-q32 |
CHRNA |
cholinergic
receptor, nicotin,
 |
18 |
S |
2 |
2 |
 |
 |
| 2q31-q32 |
NEB |
nebulin |
18 |
S |
2 |
2 |
 |
 |
| 2q33-34 |
CHRNG |
cholinergic
receptor, nicotin,
 |
[6] |
S |
2 |
1 |
 |
 |
2q34
|
FN1
|
fibronectin
1
|
[6]
|
S
|
2
|
1
|

|

|
| 3p24.3-24.2 |
RARB |
retinoic
acid receptor,
 |
16 |
S |
 |
14 |
 |
 |
| 3p21.33 |
GLB1 |
galactosidase,
,
1 |
16 |
S |
 |
9 |
B3 |
 |
| 3q21-q24 |
RHO |
rhodopsin |
16 |
S |
22 |
6 |
 |
 |
| 3q21 |
TF |
transferrin |
16q23 |
S |
1 |
9 |
 |
13q3.1 |
| 3q21-q23 |
LTF |
lactotransferrin |
16q |
I |
22 |
9 |
 |
 |
| 3q21-q24 |
CP |
ceruloplasmin |
16 |
S |
1 |
9 |
 |
13q3.2-q3.3 |
3q28
|
SST
|
somatostatin
|
19
|
S
|
1
|
16
|

|

|
|
| 4p16.3 |
FGFR3 |
fibroblast growth factor
receptor |
3 |
S |
6 |
5 |
 |
 |
| 4q11-q13 |
ALB |
albumin |
3q14 |
S,I |
6 |
5 |
 |
8q1.2 |
| 4q12 |
GC |
group
specific
component |
3 |
L |
6 |
5 |
 |
 |
| 4q12 |
KIT |
mast
cell growth factor
receptor |
3q21 |
L,I |
6 |
5 |
B1 |
8p12-p21 |
| 4q12 |
PDGFRA |
platelet
derived growth factor
A |
3q21 |
I, L |
6 |
5 |
 |
8p12 |
| 4q22 |
ADH2 |
alcohol
dehydrogenase
2 |
3 |
S |
6 |
3 |
 |
 |
| 4q22 |
ADH3 |
alcohol
dehydrogenase
3 |
3 |
S |
6 |
3 |
 |
8 |
| 4q26-q27 |
IL2 |
interleukin
2 |
2 |
S |
17 |
3 |
B1 |
8 |
4q28
|
FGG
|
fibrinogen,
polyp
|
2
|
S
|
17
|
3
|

|
8
|
| 5p13 |
IL7R |
interleukin
receptor
7 |
21 |
S |
 |
15 |
 |
 |
| 5p13-p12 |
GHR |
growth
hormone
receptor |
21 |
S |
20 |
15 |
 |
16q1.3-q1.4 |
| 5p14 |
C9 |
complement
component
9 |
21 |
S |
1 |
 |
 |
16q14 |
| 5q11-q12 |
CTLA3 |
cytotoxic
T-1 assoc serine es
3 |
21 |
S |
 |
13 |
 |
 |
| 5q13 |
HEXB |
hexoseaminidase
b |
14 |
S |
20 |
13 |
 |
 |
| 5q21-q23 |
CAMK4 |
calmodulin
depend. Prot. kinase
4 |
14 |
S |
 |
18 |
 |
 |
| 5q31.1 |
CSF2 |
colony
stimulating factor
2 |
14 |
S |
7 |
11 |
 |
5 |
| 5q31-q32 |
SPARC |
secreted
pro, ac,
cyst-rich |
14 |
S |
7 |
11 |
 |
 |
| 5q32-34 |
ADRB2 |
adrenergic
receptor,
2 |
14 |
S |
7 |
18 |
 |
 |
5q33.2-q33.3
|
CSF1R
|
colony
stimulating factor 1 receptor
|
14
|
S
|
7
|
18
|
A1
|

|
| 6pter-p21.1 |
CLPS |
colipase |
20 |
S |
 |
17 |
 |
7 |
| 6p25-p24 |
F13 |
coagulation
factor 13, A |
20q13 |
L,I |
23 |
 |
 |
4 |
| 6p21.2 |
PIM1 |
Pim-1
oncogene |
20q24 |
I |
 |
17 |
B2 |
 |
| 6p21 |
HLA |
major
histocompatibility
complex |
20q |
L,I,S |
23 |
17 |
B2 |
7 |
| 6p21.3 |
CYP21 |
cytochrome
P450 |
20 |
L |
23 |
17 |
 |
7 |
| 6p21.3 |
C4 |
complement
component
4 |
20 |
L |
23 |
17 |
 |
7 |
| 6p21.3 |
TNFA |
tumor necrosis
factor,
A |
20 |
S |
23 |
17 |
 |
7p1.1-q1.1 |
| 6q13 |
COL9A1 |
collagen
type IX,
-1 |
20q24 |
S |
 |
1 |
 |
 |
| 6q24-p23 |
EDN1 |
endothelin
1 |
20 |
S |
 |
13 |
 |
7p1.3-p1.2 |
| 6q12 |
ME1 |
malic
enzyme |
10q12 |
S,I |
9 |
9 |
B2 |
1 |
| 6q21.1-q23 |
CGA |
glycoprotein
hormone, chain |
10 |
S |
9 |
4 |
 |
1 |
| 6q21-q22.3 |
COL10A1 |
collagen,
type X, 1 |
10 |
S |
 |
10 |
 |
 |
| 6q25.1 |
ESR |
estrogen
receptor |
31q15 |
S |
9 |
6 |
 |
1p2.5-p2.4 |
| 6q26 |
PLG |
plasminogen |
31 |
S |
 |
17 |
 |
|
| 7p15-p14 |
TCRG |
T-cell
receptor, subunit |
4 |
S |
4 |
13 |
A2 |
 |
| 7q11.2 |
ELN |
elastin |
13 |
S |
25 |
5 |
 |
 |
| 7q11.23-q21 |
GUSB |
glucuronidase,
 |
13 |
S |
25 |
5 |
E3 |
 |
| 7q31.3 |
LEP |
leptin |
4 |
S |
4 |
6 |
 |
18 |
7q36
|
EN2
|
Engrailed
2
|
4
|
S
|

|
5
|

|

|
| 8q11 |
DNAPK |
DNA protein
kinase, catalytic
sub. |
9p12 |
S |
 |
16 |
 |
 |
8q24
|
TG
|
thyroglobulin
|
9
|
S
|
14
|
15
|

|

|
| 9p22 |
IFNA1 |
interferon,
-1 |
23 |
S |
8 |
4 |
 |
1 |
| 9p21 |
IFNB1 |
interferon,
-1 |
23 |
S |
8 |
4 |
 |
1 |
| 9p13 |
CNTFR |
ciliary
neurotrophic factor
receptor |
23 |
S |
8q21 |
4 |
 |
 |
| 9q31 |
TXN |
thioredoxin |
25 |
S |
8 |
4 |
 |
 |
9q33
|
GRP78
|
glucose-regulated
protein
|
25
|
S
|
11
|
2
|

|
1q2.12q2.13
|
10p13
|
VIM
|
vimentin
|
29
|
S
|
13
|
2
|

|
10
|
| 11p15.3-p15.1 |
PTH |
parathyroid
hormone |
7 |
S |
15 |
7 |
 |
2 |
| 11p15.5 |
HBB |
hemoglobin
 |
7 |
S |
15 |
7 |
D1 |
 |
| 11p15 |
TUB |
Tubby |
7 |
S |
 |
7 |
 |
 |
| 11p15.5 |
IGF2 |
insulin-like
growth factor
2 |
12q14 |
S,I |
29 |
7 |
 |
 |
| 11q12 |
CD20 |
CD20
antigen |
12 |
S |
 |
19 |
 |
 |
| 11cen-q13 |
ADRBK1 |
adrenergic
receptor kinase
1 |
12 |
S |
 |
19 |
 |
 |
| 11q22 |
PR |
progesterone
receptor |
7p16 |
I |
 |
9 |
 |
 |
| 11q23.3 |
THY1 |
Thy-1
T-cell surface
antigen |
7 |
S |
15 |
9 |
 |
 |
11q23
|
DRD2
|
dopamine
receptor
D2
|
7
|
S
|

|
9
|
|

|
| 12p12.2-p12.1 |
LDHB |
lactate
dehydrogenase
B |
[28] |
S |
5 |
6 |
B4 |
5 q12 |
| 12q13.3 |
PFKM |
phosphofructokinase
m |
[6] |
S |
5 |
 |
 |
 |
| 12q21 |
PEPB |
peptidase
B |
[28] |
S |
5 |
10 |
B4 |
5 |
| 12q22-q24.1 |
IGF1 |
insulin-like
growth factor
1 |
[28] |
S |
5 |
10 |
 |
5q2.5 |
| 12q24 |
IFNG |
interferon
 |
[6] |
S |
5 |
10 |
 |
5p1.1-q1.1 |
12q24.2
|
TCF1
|
transcription
factor
1
|
[8]
|
S
|

|
5
|

|

|
13q14.1-q14.2
|
RB1
|
retinoblastoma
|
17
|
S
|
12
|
14
|

|

|
| 14q11 |
MYH6 |
myosin,
heavy 6 |
1 |
S |
 |
14 |
 |
 |
| 14q11.2 |
CHY |
Chymase,
mast
cell |
1 |
S |
 |
11 |
 |
 |
| 14q13.1 |
NP |
nucleoside
phosphorylase |
1q26 |
S,I |
10 |
14 |
B3 |
7q2.1-q2.2 |
14q32.1
|
PI/AAT
|
protease
inhibitor/AAT
|
24q15
|
L,I
|
7
|
12
|

|
7q2.4-q2.6
|
| 15q22-qter |
MPI |
mannose
phosphate
isomerase |
1 |
S |
21 |
9 |
B3 |
7 |
| 15q22-qter |
CYP1A2 |
cytochrome
P450, subf. I, polyp.
2 |
1 |
S |
 |
9 |
 |
 |
| 15q25-q26 |
IGF1R |
insulin-1
growth factor 1 receptor |
1 |
S |
21 |
7 |
 |
1q1.7-q1.2 |
| 15q26.1 |
IDH2 |
isocitrate
dehydrogenase
2 |
1 |
S |
 |
7 |
B3 |
 |
15q26.1
|
FES
|
feline
sarcoma virus
homologue
|
1
|
S
|
21
|
7
|
B3
|

|
| 16pter-p13.3 |
HBA |
hemoglobin
A |
13q |
I,L |
 |
11 |
 |
 |
| 16p24.3 |
MC1R |
melanocortin
receptor |
3p12 |
L,S,I |
18 |
8 |
 |
 |
| 16q13-q22.1 |
CES1 |
carboxylesterase |
3 |
L |
 |
8 |
 |
 |
| 16q21 |
GOT2 |
glutamate
oxaloact. transam.,
mito |
3p15 |
I,L |
 |
8 |
 |
 |
16q22.1
|
HP
|
haptoglobin
|
3
|
L
|
18
|
8
|

|

|
| 17q11.2 |
EVI2A |
ecotropic
viral integration
site2A |
11 |
S |
 |
11 |
 |
 |
| 17q11.2 |
NF1 |
neurofibromatosis
1 |
11 |
S |
19 |
11 |
 |
 |
| 17q21 |
MYL4 |
myosin, light
chain 4 |
11 |
S |
19 |
11 |
|
|
| 17q22-q24 |
GH |
growth
hormone |
11 |
S |
19 |
11 |
 |
12p1.2-p1.5 |
| 17q23.1-q25.3 |
HYPP |
hyperkalemic
periodic
paralysis |
11 |
S |
 |
11 |
 |
 |
| 17q25 |
P4HB |
prolyl-4
hydroxylase  |
11 |
S |
19 |
11 |
 |
|
18p11.32
|
TS
|
thymidylate
synthetase
|
[8]
|
S
|
24
|
5
|

|

|
| 19p13.3-p13.2 |
C3 |
complement
component
3 |
7pter |
I,S |
 |
17 |
 |
2p17-p14 |
| 19cen-q13.2 |
A1BG |
globulin,
A1 |
10 |
L |
 |
 |
 |
 |
| 19q13.1 |
GPI |
glucose
phosphate
isomerase |
10pter |
I |
18 |
7 |
 |
6q12 |
| 19q13 |
CRC |
calcium
release
channel |
10pter |
I |
18 |
 |
 |
6q12 |
19q13
|
CKM
|
creatine
kinase,
muscle
|
10
|
S
|
-
|
7
|

|

|
| 20pterp12 |
PRNP |
prion
protein |
22 |
S |
13 |
2 |
 |
 |
| 20q11.2 |
GHRH |
growth
hormone releasing
hormone |
22 |
S |
13 |
2 |
 |
 |
| 20q11.2 |
ASP |
agouti
signaling
protein |
22q15 |
S,I |
 |
2 |
 |
 |
| 20q13.11 |
ADA |
adenosine
deaminase |
22 |
S |
13 |
2 |
A3 |
 |
20q13.2
|
GNAS1
|
guanine
nucleotide-binding
protein
|
22
|
S
|
13
|
2
|

|

|
| 21q22.3 |
MX1 |
myxovirus
resistance
|
26q17 |
I |
1 |
16 |
 |
13 |
21q22.3
|
ETS2
|
avian
erythroblastosis virus onc.
2
|
26q17
|
I,S
|
1
|
16
|
C2
|

|
| 22q13.31-qter |
ARSA |
arylsulfatase
A |
[28] |
S |
 |
15 |
 |
 |
22q13.1
|
CYP2D
|
cytochrome
P450, subfamily
IID
|
[28]
|
S
|
5
|
15
|

|

|
| Xp11.21 |
ALAS2 |
anemia,
hereditary
sideroblastic |
X |
S |
 |
X |
 |
 |
| Xq27.1-q27.2 |
F9 |
coagulation
factor
9 |
X |
S |
X |
X |
X |
X |
| Xq28 |
G6PD |
glucose 6 phosphate
dehydrogenase |
X |
S |
X |
X |
X |
X |
| Xq28 |
BGN |
biglycan |
X |
S |
 |
X |
 |
 |
| Xq28 |
F18 |
factor
18 |
Xq29 |
S,I |
 |
 |
 |
 |
|
|
a
Data retrieved from Online Mendelian Inheritance in
Man (OMIM), Johns Hopkins University, Baltimore, MD (March 1999). Full
references are available at
http://www3.ncbi.nlm.nih.gov/omim/.
|
|
b
ECA assignment as in Shiue et al. (1999). In
bold, physically assigned markers.
|
|
c
Method: (I) In situ hybridization; (L) linkage; (S)
synteny. Full references available at
http://www.vgl.ucdavis.edu/horse.
|
|
d
Data retrieved from Bovmap Database, INRA, Laboratoire de
Génétique Biochimique et de Cytogénétique de Jouy-en-Josas
(March 1999). Full references are available at
http://locus.jouy.inra.fr/cgi-bin/bovmap/intro.pl. and The
Cattle Mapping Database (ARKDB), Roslin Institute, UK (March 1999).
Full references available at
http://www.ri.bbsrc.ac.uk/cgi-bin/arkdb/browsers/browser.sh?species=cattle
|
|
e
Data retrieved from Mouse Genome Informatics (MGI)
Resource, Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor,
Maine (March 1999). Full references are available at
http://www.informatics.jax.org/.
|
|
f
Data retrieved from O'brien et al. (1997b).
|
|
g
Data retrieved from PiGBASE, Roslin Institute, Edinburgh,
UK (May 1998). Full references are available at
http://www.ri.bbsrc.ac.uk/pigmap/pigbase/pigbase.html.
|
|